Open | $5.850 |
Close | $5.490 |
Volume / Avg. | 193.030K / 254.804K |
Day Range | 5.460 - 5.950 |
52 Wk Range | 4.630 - 12.750 |
Market Cap | $197.939M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | % |
Days to Cover | 20.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of scPharmaceuticals (NASDAQ: SCPH) through any online brokerage.
Other companies in scPharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), SNDL (NASDAQ:SNDL), Xeris Biopharma Holdings (NASDAQ:XERS) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for scPharmaceuticals (NASDAQ: SCPH) was reported by HC Wainwright & Co. on Thursday, March 14, 2024. The analyst firm set a price target for 18.00 expecting SCPH to rise to within 12 months (a possible 227.87% upside). 9 analyst firms have reported ratings in the last year.
The stock price for scPharmaceuticals (NASDAQ: SCPH) is $5.49 last updated March 18, 2024 at 4:01 PM EDT.
There are no upcoming dividends for scPharmaceuticals.
scPharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for scPharmaceuticals.
scPharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.